首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical medicine insights-oncology

缩写:

ISSN:N/A

e-ISSN:1179-5549

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引526
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mathieu Chevallier,Floryane Kim,Alex Friedlaender et al. Mathieu Chevallier et al.
Over the course of the last decade, immunotherapy has revolutionised the management of a great number of cancer types. The treatment of pleural mesothelioma, a rare and highly aggressive cancer, is also being transformed by immunotherapy. T...
Jie Chen,Zhichao Fu,Yunyun Zhu Jie Chen
Background: With the update of equipment, the hospital base of this study began to adopt craniospinal irradiation (CSI) intensity-modulated radiotherapy (IMRT) in May 2018 to replace the traditional CSI conventional radio...
Hejing Wang,Lina Qi,Chenhan Zhong et al. Hejing Wang et al.
Background: The neurotrophic tyrosine kinase (NTRK) gene family includes NTRK1, NTRK2, and NTRK3, which encode tropomyosin receptor kinases TrkA, TrkB, and TrkC, respectively. This study aimed to initially assess the geno...
Wei Li,Xinyu Wu,Heng Yu et al. Wei Li et al.
Background: Denosumab entered the Chinese market for the first time in 2020. Since it is a short period of time, there is a lack of data on its effectiveness and safety in Chinese people. The objective of this study was t...
Jun Yin,Wenya Yin,Linlin Zheng et al. Jun Yin et al.
Background: Anlotinib is a multi-target anti-angiogenic agent. The retrospective study was conducted to evaluate the safety and effectiveness of anlotinib as monotherapy or combination therapy for the treatment of recurre...
Nasser Shakhssalim,Mehdi Dadpour,Farzaneh Sharifiaghdas et al. Nasser Shakhssalim et al.
Background: It is estimated that 75% of urothelial bladder cancers are non-muscle-invasive cancers (NMIBCs). The development of more effective methods for optimizing the management of this subset of patients is of paramou...
Jingheng Guo,Qian Cheng,Yongjian Li et al. Jingheng Guo et al.
Background: The incidence of intrahepatic cholangiocarcinoma (ICC) is increasing globally, and its prognosis has not improved substantially in recent years. Understanding the pathogenesis of ICC may provide a theoretical ...
Yue Zhang,Yanyan Wang,Menglin Zhao et al. Yue Zhang et al.
Background: Gastric cancer (GC) is the fifth leading cancer in the world, and there is a high mortality rate in China. Exploring the relationship between the prognosis of GC and the expression of related genes is helpful ...
Theresa Nwagha,Martins Nweke Theresa Nwagha
Background: Several biomarkers or risk factors have been identified and several prediction models exist. The major limitations inherent in these models include cost-ineffectiveness and lack of systematic stratification of...
Dongxu Zhao,Wei Xu,Yi Zhan et al. Dongxu Zhao et al.
Background: Recent studies have shown that inflammatory indicators are closely related to the prognosis of patients with hepatocellular carcinoma, and they can serve as powerful indices for predicting recurrence and survi...